Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Clobetasol Propionate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,008Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Formosa & Medvisis Announce Licensing Deal For Clobetasol
    Formosa & Medvisis Announce Licensing Deal For Clobetasol

    28 Nov 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/formosa-pharmaceuticals-and-medvisis-switzerland-announce-licensing-agreement-for-clobetasol-propionate-ophthalmic-suspension-for-the-treatment-of-post-operative-inflammation-and-pain-302318160.html

    PR NEWSWIRE
    28 Nov 2024
    Share Share
    Formosa & DÁVI Farmacêutica Announce Clobetasol Licensing Deal
    Formosa & DÁVI Farmacêutica Announce Clobetasol Licensing Deal

    31 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/formosa-pharmaceuticals-and-davi-farmaceutica-announce-licensing-agreement-for-clobetasol-propionate-ophthalmic-suspension-for-the-treatment-of-post-operative-inflammation-and-pain-302292975.html

    PR NEWSWIRE
    31 Oct 2024
    Share Share
    Eyenovia Presents Phase 3 Clobetasol Study Results At AAO Expo
    Eyenovia Presents Phase 3 Clobetasol Study Results At AAO Expo

    16 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/16/2963893/0/en/Eyenovia-Announces-Presentation-of-Phase-3-Clobetasol-Study-Results-at-the-American-Academy-of-Ophthalmology-AAO-2024-Expo.html

    GLOBENEWSWIRE
    16 Oct 2024
    Share Share
    Formosa Ships APP13007 To US For Commercialization
    Formosa Ships APP13007 To US For Commercialization

    09 Sep 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/formosa-pharmaceuticals-makes-first-shipment-of-app13007-clobetasol-propionate-ophthalmic-suspension-0-05-to-the-united-states-for-commercialization-302241470.html

    PR NEWSWIRE
    09 Sep 2024
    Share Share
    Eyenovia Announces Taiwan Export License Approval
    Eyenovia Announces Taiwan Export License Approval

    05 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/05/2941189/0/en/Eyenovia-Announces-Taiwan-Export-License-Approval-to-Commence-Shipment-of-Clobetasol-Propionate-Ophthalmic-Suspension-0-05-to-the-U-S.html

    GLOBENEWSWIRE
    05 Sep 2024
    Share Share
    Formosa Pharma Licenses Clobetasol Ophthalmic Drug To Apotex
    Formosa Pharma Licenses Clobetasol Ophthalmic Drug To Apotex

    05 Sep 2024

    // PRESS RELEASE

    https://www.formosalab.com/news-list-page612

    PRESS RELEASE
    05 Sep 2024
    Share Share